# NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis

> **NCT05734599** · — · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 1194 (estimated)

## Conditions studied

- Metabolic Dysfunction-associated Fatty Liver Disease
- Metabolic Disease

## Interventions

- **DEVICE:** NMR-based metabolic profiling

## Key facts

- **NCT ID:** NCT05734599
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-01
- **Target enrollment:** 1194 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734599, "NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05734599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*